Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is N/A as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1272.93%.
OPERATING MARGIN
N/A
OPERATING MARGIN AVG TTM
-870.34%
OPERATING MARGIN AVG 3Y
-651.49%
OPERATING MARGIN AVG 5Y
-636.95%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
CytoMed Therapeutics Limited
Market Cap
$11.95M
Operating Margin
N/A
TTM Avg
-870.34%
3Y Avg
-651.49%
5Y Avg
-636.95%
Market Cap
$11.94M
Operating Margin
-5.39%
TTM Avg
-4.88%
3Y Avg
-13.74%
5Y Avg
-13.69%
Market Cap
$12.46M
Operating Margin
-33.37%
TTM Avg
-42.32%
3Y Avg
-69.57%
5Y Avg
-60.22%
Market Cap
$11.42M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.41M
Operating Margin
-21.94%
TTM Avg
-34.04%
3Y Avg
-49.86%
5Y Avg
-59.16%
Market Cap
$12.63M
Operating Margin
-1315.51%
TTM Avg
-120503.86%
3Y Avg
-60605.86%
5Y Avg
-40403.91%
Market Cap
$11.01M
Operating Margin
-5652.38%
TTM Avg
-2826.19%
3Y Avg
-9617.03%
5Y Avg
-6411.35%
Market Cap
$10.74M
Operating Margin
-293.46%
TTM Avg
-272.89%
3Y Avg
-2404.23%
5Y Avg
-2129.99%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CytoMed Therapeutics Limited (GDTC) | $11.95M | N/A | -870.34% | -651.49% | -636.95% |
| IRIDEX Corporation (IRIX)vs › | $11.94M | -5.39% | -4.88% | -13.74% | -13.69% |
| Cytosorbents Corporation (CTSO)vs › | $12.46M | -33.37% | -42.32% | -69.57% | -60.22% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| Biofrontera Inc. (BFRI)vs › | $11.41M | -21.94% | -34.04% | -49.86% | -59.16% |
| Dare Bioscience, Inc. (DARE)vs › | $12.63M | -1315.51% | -120503.86% | -60605.86% | -40403.91% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.01M | -5652.38% | -2826.19% | -9617.03% | -6411.35% |
| BioVie Inc. (BIVI)vs › | $10.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cerenome, Inc. (CNSY)vs › | $10.74M | -293.46% | -272.89% | -2404.23% | -2129.99% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.34M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
N/A
Operating Margin
N/A
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -1272.93% |
| 2025-12-31 | -1403.07% |
| 2025-09-30 | -322.37% |
| 2025-06-30 | -483.00% |
| 2025-03-31 | -483.00% |
| 2024-12-31 | -2348.68% |
| 2024-09-30 | -366.26% |
| 2024-06-30 | -473.26% |
| 2024-03-31 | -473.26% |
| 2023-12-31 | -390.87% |
| 2023-09-30 | -390.87% |
| 2023-06-30 | -1107.51% |
| 2023-03-31 | -714.08% |
| 2022-12-31 | -950.17% |
| 2022-09-30 | -258.76% |
| 2022-06-30 | -847.41% |
| 2022-03-31 | -847.41% |
| 2021-12-31 | -2504.02% |
| 2021-09-30 | -680.96% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | -2003.14% |
| 2020-12-31 | -1191.30% |
| 2020-09-30 | -1146.76% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
